Prevalence of polypharmacy and associated adverse health outcomes in adult patients with chronic kidney disease: protocol for a systematic review and meta-analysis.

Okpechi, Ikechi G; Tinwala, Mohammed M; Muneer, Shezel; Zaidi, Deenaz; Ye, Feng; Hamonic, Laura N; Khan, Maryam; Sultana, Naima; Brimble, Scott; Grill, Allan; +13 more... Klarenbach, Scott; Lindeman, Cliff; Molnar, Amber; Nitsch, Dorothea; Ronksley, Paul; Shojai, Soroush; Soos, Boglarka; Tangri, Navdeep; Thompson, Stephanie; Tuot, Delphine; Drummond, Neil; Mangin, Dee; Bello, Aminu K; (2021) Prevalence of polypharmacy and associated adverse health outcomes in adult patients with chronic kidney disease: protocol for a systematic review and meta-analysis. Systematic reviews, 10 (1). 198-. ISSN 2046-4053 DOI: https://doi.org/10.1186/s13643-021-01752-z

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1186/s13643-021-01752-z

Abstract

Share

Download

Filename: Prevalence of polypharmacy and associated adverse health outcomes in adult patients with chronic kidney disease protocol for.pdf

Licence: Creative Commons: Attribution 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar